This study aimed to assess the association between fat mass and obesity-associated (FTO) genetic variants and colorectal cancer (CRC) risk in a retrospective case–control cohort. FTO expression in CRC versus normal tissues was analyzed via UALCAN (TCGA), and the regulatory effects of rs9930506 and rs9940128 were assessed using GTEx data. A retrospective analysis was conducted on 870 CRC cases and 870 matched controls. Genotyping was performed using PCR-RFLP. Association with CRC risk was assessed by unconditional logistic regression with odds ratio (OR) and 95% confidence interval (CI), adjusted for age, sex, smoking status, and drinking status. Bioinformatics analysis revealed elevated FTO expression in colon cancer (p = 0.043), but not in rectal cancer (p = 0.250). Its variants rs9930506 and rs9940128 showed regulatory effects on gene expression in skeletal muscle and esophagogastric junction (p < 0.001). The FTO variant rs9930506 A > G was significantly associated with reduced CRC risk across multiple genetic models (GG vs. AA: OR = 0.30, 95% CI = 0.16–0.56, p < 0.001; AG+GG vs. AA: OR = 0.76, 95% CI = 0.62–0.93, p = 0.007; GG vs. AG+AA: OR = 0.32, 95% CI = 0.17–0.59, p < 0.001). These protective associations were preserved in non-smokers (all p < 0.05) and non-drinkers (all p < 0.01). In contrast, rs9940128 showed no significant association with CRC risk in any genetic model or stratum (all p > 0.05). The FTO rs9930506 polymorphism is associated with reduced CRC risk in this population, suggesting its role as a potential susceptibility marker.
AlmawiWY, NemrR, AtazhanovaT, et al.Differential association of FTO gene variants and haplotypes with the susceptibility to polycystic ovary syndrome according to obesity in women with PCOS. Reprod Sci, 2023; 30(7):2166–2176; doi: 10.1007/s43032-022-01149-w
2.
ArnoldM, SierraMS, LaversanneM, et al.Global patterns and trends in colorectal cancer incidence and mortality. Gut, 2017; 66(4):683–691; doi: 10.1136/gutjnl-2015-310912
3.
Azizzadeh-RoodpishS, GarzonMH, MainaliS. Classifying single nucleotide polymorphisms in humans. Mol Genet Genomics, 2021; 296(5):1161–1173; doi: 10.1007/s00438-021-01805-x
4.
AzzamSK, AlsafarH, SajiniAA. FTO m6A demethylase in obesity and cancer: Implications and underlying molecular mechanisms. Int J Mol Sci, 2022; 23(7):3800; doi: 10.3390/ijms23073800
5.
BadraldinSQ, AlfarttoosiKH, SameerHN, et al.Mechanistic role of FTO in cancer pathogenesis, immune evasion, chemotherapy resistance, and immunotherapy response. Semin Oncol, 2025; 52(3):152368; doi: 10.1016/j.seminoncol.2025.152368
6.
BagnardiV, RotaM, BotteriE, et al.Alcohol consumption and site-specific cancer risk: A comprehensive dose-response meta-analysis. Br J Cancer, 2015; 112(3):580–593; doi: 10.1038/bjc.2014.579
7.
BerulavaT, HorsthemkeB. The obesity-associated SNPs in intron 1 of the FTO gene affect primary transcript levels. Eur J Hum Genet, 2010; 18(9):1054–1056; doi: 10.1038/ejhg.2010.71
8.
BerulavaT, ZieheM, Klein-HitpassL, et al.FTO levels affect RNA modification and the transcriptome. Eur J Hum Genet, 2013; 21(3):317–323; doi: 10.1038/ejhg.2012.168
9.
BrayF, LaversanneM, SungH, et al.Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2024; 74(3):229–263; doi: 10.3322/caac.21834
10.
BrennerH, ChenC. The colorectal cancer epidemic: Challenges and opportunities for primary, secondary and tertiary prevention. Br J Cancer, 2018; 119(7):785–792; doi: 10.1038/s41416-018-0264-x
11.
CaliriAW, TommasiS, BesaratiniaA. Relationships among smoking, oxidative stress, inflammation, macromolecular damage, and cancer. Mutat Res Rev Mutat Res, 2021; 787:108365; doi: 10.1016/j.mrrev.2021.108365
12.
ChenX, GaoY, YangX, et al.Relationship of FTO gene variations with NAFLD risk in chinese men. Open Life Sci, 2020; 15(1):860–867; doi: 10.1515/biol-2020-0081
DingY, QiN, WangK, et al.FTO facilitates lung adenocarcinoma cell progression by activating cell migration through mRNA demethylation. Onco Targets Ther, 2020; 13:1461–1470; doi: 10.2147/ott.S231914
15.
DoaeiS, BourbourF, RastgooS, et al.Interactions of anthropometric indices, rs9939609 FTO gene polymorphism and breast cancer: A case-control study. J Cell Mol Med, 2021; 25(7):3252–3257; doi: 10.1111/jcmm.16394
16.
FranczakA, KolačkovK, Jawiarczyk-PrzybyłowskaA, et al.Association between FTO gene polymorphisms and HDL cholesterol concentration may cause higher risk of cardiovascular disease in patients with acromegaly. Pituitary, 2018; 21(1):10–15; doi: 10.1007/s11102-017-0840-8
17.
FreislingH, ArnoldM, SoerjomataramI, et al.Comparison of general obesity and measures of body fat distribution in older adults in relation to cancer risk: Meta-analysis of individual participant data of seven prospective cohorts in Europe. Br J Cancer, 2017; 116(11):1486–1497; doi: 10.1038/bjc.2017.106
18.
GerkenT, GirardCA, TungY-CL, et al.The obesity-associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase. Science, 2007; 318(5855):1469–1472; doi: 10.1126/science.1151710
19.
GholamalizadehM, AkbariME, DoaeiS, et al.The association of fat-mass-and obesity-associated gene polymorphism (rs9939609) with colorectal cancer: A case-control study. Front Oncol, 2021; 11:732515; doi: 10.3389/fonc.2021.732515
20.
GholamalizadehM, JonoushM, MobarakehKA, et al.The effects of FTO gene rs9939609 polymorphism on the association between colorectal cancer and dietary intake. Front Nutr, 2023; 10:1215559; doi: 10.3389/fnut.2023.1215559
21.
Górczyńska-KosiorzS, LejawaM, GoławskiM, et al.The impact of haplotypes of the FTO gene, lifestyle, and dietary patterns on BMI and metabolic syndrome in polish young adult men. Nutrients, 2024; 16(11):1615; doi: 10.3390/nu16111615
22.
Hernández-CaballeroME, Sierra-RamírezJA, Peña-GutierrezM, et al.Investigating the role of fat mass and Obesity-Associated (FTO) single nucleotide polymorphisms and methylation in breast cancer. Cureus, 2024; 16(6):e62851; doi: 10.7759/cureus.62851
23.
HuangX, ZhaoJ, YangM, et al.Association between FTO gene polymorphism (rs9939609 T/A) and cancer risk: A meta-analysis. Eur J Cancer Care (Engl), 2017; 26(5); doi: 10.1111/ecc.12464
24.
JiaG, FuY, ZhaoX, et al.N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO. Nat Chem Biol, 2011; 7(12):885–887; doi: 10.1038/nchembio.687
25.
JiangX, LiuB, NieZ, et al.The role of m6A modification in the biological functions and diseases. Signal Transduct Target Ther, 2021; 6(1):74; doi: 10.1038/s41392-020-00450-x
26.
KarraE, O’DalyOG, ChoudhuryAI, et al.A link between FTO, ghrelin, and impaired brain food-cue responsivity. J Clin Invest, 2013; 123(8):3539–3551; doi: 10.1172/jci44403
27.
LanN, LuY, ZhangY, et al.FTO - A common genetic basis for obesity and cancer. Front Genet, 2020; 11:559138; doi: 10.3389/fgene.2020.559138
28.
LiA, GaoH, WuH, et al.Genetic association and functional implications of TLR4 rs1927914 polymorphism on Colon cancer risk. BMC Cancer, 2024a;24(1):858; doi: 10.1186/s12885-024-12604-z
29.
LiJ, LiS, XingX, et al.FTO-mediated ZNF687 accelerates tumor growth, metastasis, and angiogenesis in colorectal cancer through the wnt/β-catenin pathway. Biotechnol Appl Biochem, 2024b;71(2):245–255; doi: 10.1002/bab.2536
30.
LiY, SuR, DengX, et al.FTO in cancer: Functions, molecular mechanisms, and therapeutic implications. Trends Cancer, 2022; 8(7):598–614; doi: 10.1016/j.trecan.2022.02.010
31.
LiZ, WengH, SuR, et al.FTO plays an oncogenic role in acute myeloid leukemia as a N6-Methyladenosine RNA demethylase. Cancer Cell, 2017; 31(1):127–141; doi: 10.1016/j.ccell.2016.11.017
32.
LiuS, HuangM, ChenZ, et al.FTO promotes cell proliferation and migration in esophageal squamous cell carcinoma through up-regulation of MMP13. Exp Cell Res, 2020; 389(1):111894; doi: 10.1016/j.yexcr.2020.111894
33.
MansoorQ, IsmailM, QaderSAU. Linkage disequilibrium block single-nucleotide polymorphisms in FTO alpha ketoglutarate dependent dioxygenase gene inference with breast cancer and type II diabetes in pakistani female population. PLoS One, 2023; 18(7):e0288934; doi: 10.1371/journal.pone.0288934
34.
MbemiA, KhannaS, NjikiS, et al.Impact of gene-environment interactions on cancer development. Int J Environ Res Public Health, 2020; 17(21):8089; doi: 10.3390/ijerph17218089
35.
MontazeriF, HatamiH, FathiS, et al.FTO genotype was associated with breast cancer in HER2 negative patients. Clin Nutr ESPEN, 2022; 49:495–498; doi: 10.1016/j.clnesp.2022.02.122
36.
MyburghMW, SchwerdtfegerKS, CripwellRA, et al.Promoters and introns as key drivers for enhanced gene expression in Saccharomyces cerevisiae. Adv Appl Microbiol, 2023; 124:1–29; doi: 10.1016/bs.aambs.2023.07.002
37.
NiuY, LinZ, WanA, et al.RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3. Mol Cancer, 2019; 18(1):46; doi: 10.1186/s12943-019-1004-4
38.
O’SullivanDE, SutherlandRL, TownS, et al.Risk factors for early-onset colorectal cancer: A systematic review and meta-analysis. Clin Gastroenterol Hepatol, 2022; 20(6):1229–1240; doi: 10.1016/j.cgh.2021.01.037
39.
OlssonJB, GugerelMB, JessenSB, et al.Colorectal cancer-associated SNP rs17042479 is involved in the regulation of NAF1 promoter activity. PLoS One, 2022; 17(9):e0274033; doi: 10.1371/journal.pone.0274033
40.
QiJ, LiM, WangL, et al.National and subnational trends in cancer burden in China, 2005-20: An analysis of national mortality surveillance data. Lancet Public Health, 2023; 8(12):e943–e955; doi: 10.1016/s2468-2667(23)00211-6
41.
QiaoY, SuM, ZhaoH, et al.Correction: Targeting FTO induces colorectal cancer ferroptotic cell death by decreasing SLC7A11/GPX4 expression. J Exp Clin Cancer Res, 2024; 43(1):131; doi: 10.1186/s13046-024-03051-6
42.
RamyaK, RadhaV, GhoshS, et al.Genetic variations in the FTO gene are associated with type 2 diabetes and obesity in South indians (CURES-79). Diabetes Technol Ther, 2011; 13(1):33–42; doi: 10.1089/dia.2010.0071
43.
RelierS, RipollJ, GuilloritH, et al.FTO-mediated cytoplasmic m6Am demethylation adjusts stem-like properties in colorectal cancer cell. Nat Commun, 2021; 12(1):1716; doi: 10.1038/s41467-021-21758-4
44.
RelierS, RivalsE, DavidA. The multifaceted functions of the fat mass and obesity-associated protein (FTO) in normal and cancer cells. RNA Biol, 2022; 19(1):132–142; doi: 10.1080/15476286.2021.2016203
45.
RischNJ. Searching for genetic determinants in the new millennium. Nature, 2000; 405(6788):847–856; doi: 10.1038/35015718
46.
RossiM, AnwarMJ, UsmanA, et al.Colorectal cancer and alcohol consumption-populations to molecules. Cancers (Basel), 2018; 10(2):38; doi: 10.3390/cancers10020038
47.
RuanD-Y, LiT, WangY-N, et al.FTO downregulation mediated by hypoxia facilitates colorectal cancer metastasis. Oncogene, 2021; 40(33):5168–5181; doi: 10.1038/s41388-021-01916-0
48.
SaadatM. The importance of examining the Hardy-Weinberg equilibrium in genetic association studies. Mol Biol Res Commun, 2024; 13(1):1–2; doi: 10.22099/mbrc.2023.48386.1872
49.
Saldaña-AlvarezY, Salas-MartínezMG, García-OrtizH, et al.Gender-Dependent association of FTO polymorphisms with body mass index in mexicans. PLoS One, 2016; 11(1):e0145984; doi: 10.1371/journal.pone.0145984
50.
Salgado-MontillaJL, Rodríguez-CabánJL, Sánchez-GarcíaJ, et al.Impact of FTO SNPs rs9930506 and rs9939609 in prostate cancer severity in a cohort of puerto rican men. Arch Cancer Res, 2017; 5(3):148; doi: 10.21767/2254-6081.1000148
51.
ScuteriA, SannaS, ChenW-M, et al.Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits. PLoS Genet, 2007; 3(7):e115; doi: 10.1371/journal.pgen.0030115
52.
ShaulO. How introns enhance gene expression. Int J Biochem Cell Biol, 2017; 91(Pt B):145–155; doi: 10.1016/j.biocel.2017.06.016
53.
ShenX-P, LingX, LuH, et al.Low expression of microRNA-1266 promotes colorectal cancer progression via targeting FTO. Eur Rev Med Pharmacol Sci, 2018; 22(23):8220–8226; doi: 10.26355/eurrev_201812_16516
54.
SlatkinM. Linkage disequilibrium–understanding the evolutionary past and mapping the medical future. Nat Rev Genet, 2008; 9(6):477–485; doi: 10.1038/nrg2361
55.
SuR, DongL, LiC, et al.R-2HG exhibits anti-tumor activity by targeting FTO/m6A/MYC/CEBPA signaling. Cell, 2018; 172(1–2):90–105; doi: 10.1016/j.cell.2017.11.031
56.
VieiraAR, AbarL, ChanDSM, et al.Foods and beverages and colorectal cancer risk: A systematic review and meta-analysis of cohort studies, an update of the evidence of the WCRF-AICR continuous update project. Ann Oncol, 2017; 28(8):1788–1802; doi: 10.1093/annonc/mdx171
57.
YanT, ShenC, JiangP, et al.Risk SNP-induced lncRNA-SLCC1 drives colorectal cancer through activating glycolysis signaling. Signal Transduct Target Ther, 2021; 6(1):70; doi: 10.1038/s41392-020-00446-7
58.
YaoJ, DingD, LiX, et al.Prevalent intron retention fine-tunes gene expression and contributes to cellular senescence. Aging Cell, 2020; 19(12):e13276; doi: 10.1111/acel.13276
59.
YueC, ChenJ, LiZ, et al.microRNA-96 promotes occurrence and progression of colorectal cancer via regulation of the AMPKα2-FTO-m6A/MYC axis. J Exp Clin Cancer Res, 2020; 39(1):240; doi: 10.1186/s13046-020-01731-7
60.
ZhangJ, MengX, ZhaoB, et al.FTO promotes the progression of triple-negative breast cancer by regulating the m6A methylation of NFKBIE. Clin Exp Med, 2025a;25(1):320; doi: 10.1007/s10238-025-01872-z
61.
ZhangX, WuW, LiH, et al.STING rs7380824 polymorphism contributes to the susceptibility of colorectal cancer in chinese population. DNA Cell Biol, 2025b;44(7):380–388; doi: 10.1089/dna.2025.0020
62.
ZhangX, YangL, LiuS, et al.Interpretation on the report of global cancer statistics 2022. Zhonghua Zhong Liu Za Zhi, 2024; 46(7):710–721; doi: 10.3760/cma.j.cn112152-20240416-00152
63.
ZhuT, TanJZA, ZhangL, et al.FTO suppresses DNA repair by inhibiting PARP1. Nat Commun, 2025; 16(1):2925; doi: 10.1038/s41467-025-58309-0
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
